Agios is passionately committed to the fundamental transformation of patients' lives through scientific leadership in the field of cancer metabolism.

Agios is an independent, private biopharmaceutical company at the forefront of one of the most exciting new areas of cancer research: cancer metabolism. Cancer metabolism represents a breakthrough understanding of how cancer cells become "addicted" to using more nutrients than normal cells to ensure their survival and fuel their growth.